Exercise as medicine for COVID-19: On PPAR with emerging pharmacotherapy
Kevin S. Heffernan, Sushant M. Ranadive, Sae Young Jae
Topics & Concepts
LipotoxicityCoronavirusInflammationEndothelial dysfunctionDiabetes mellitusPathogenesisMedicineMetabolic syndromePeroxisome proliferator-activated receptorType 2 Diabetes MellitusFenofibrateDiseaseImmunologyBiologyReceptorBioinformaticsCoronavirus disease 2019 (COVID-19)Internal medicineInsulin resistanceEndocrinologyInfectious disease (medical specialty)Adipose Tissue and MetabolismCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19